Savara Inc. (Nasdaq: SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, reported financial results for the third ...
This study is led by Professor Rong Hu's team from the Department of Neurosurgery and Key Laboratory of Neurotrama, Southwest Hospital, Third Military ...
Bria-OTS+â„¢ further expresses multiple immune activating cytokines and co-stimulatory molecules in addition to immune boosting granulocyte-macrophage colony-stimulating factor (GM-CSF). The Bria-OTS+â„¢ ...
Ulcerative colitis (UC) is a chronic gut inflammatory condition affecting the colon in humans. This study uses human samples as well as a mouse model of colitis induced by a chemical, DSS, to ...
This observation prompted us to use clodronate liposomes in this study. Future work will need to determine whether CSF-1 blockade or other macrophage targeting modalities, initiated after CSS onset, ...
Some results have been hidden because they may be inaccessible to you